Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain
出版年份 2014 全文链接
标题
Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 19, Issue 1, Pages 25-35
出版商
Informa Healthcare
发表日期
2014-10-15
DOI
10.1517/14728222.2014.957673
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy
- (2014) Maree T. Smith et al. BEHAVIOURAL PHARMACOLOGY
- Targeting Nerve Growth Factor (NGF) for Pain Management: What Does the Future Hold for NGF Antagonists?
- (2014) Bernard Bannwarth et al. DRUGS
- EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial
- (2014) Andrew S C Rice et al. LANCET
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy
- (2014) Simon Haroutounian et al. PAIN
- Angiotensin II Receptor Type 2 Activation Is Required for Cutaneous Sensory Hyperinnervation and Hypersensitivity in a Rat Hind Paw Model of Inflammatory Pain
- (2013) Anuradha Chakrabarty et al. JOURNAL OF PAIN
- Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonists as Novel Analgesics for Neuropathic Pain: Comparative Pharmacokinetics, Radioligand Binding, and Efficacy in Rats
- (2013) Maree T. Smith et al. PAIN MEDICINE
- A Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonist Produces Analgesia in a Rat Model of Neuropathic Pain by Inhibition of p38 Mitogen-Activated Protein Kinase (MAPK) and p44/p42 MAPK Activation in the Dorsal Root Ganglia
- (2013) Maree T. Smith et al. PAIN MEDICINE
- Analgesic Efficacy and Mode of Action of a Selective Small Molecule Angiotensin II Type 2 Receptor Antagonist in a Rat Model of Prostate Cancer-Induced Bone Pain
- (2013) Arjun Muralidharan et al. PAIN MEDICINE
- Optimization and characterization of a rat model of prostate cancer-induced bone pain using behavioral, pharmacological, radiological, histological and immunohistochemical methods
- (2013) Arjun Muralidharan et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments
- (2013) Arjun Muralidharan et al. INFLAMMOPHARMACOLOGY
- Angiotensin II type 2 receptor (AT2R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons
- (2012) U. Anand et al. EUROPEAN JOURNAL OF PAIN
- Angiotensin II type 2 receptor agonists – where should they be applied?
- (2012) Ulrike Muscha Steckelings et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Angiotensin II type 2 receptor agonists: where should they be applied?
- (2012) Koen Verdonk et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pregabalin for the treatment of fibromyalgia
- (2012) Maree T Smith et al. EXPERT OPINION ON PHARMACOTHERAPY
- Mechanistic and functional differentiation of tapentadol and tramadol
- (2012) Robert B Raffa et al. EXPERT OPINION ON PHARMACOTHERAPY
- Enhanced Excitability of Small Dorsal Root Ganglion Neurons in Rats with Bone Cancer Pain
- (2012) Qin Zheng et al. Molecular Pain
- An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
- (2012) John P. Huggins et al. PAIN
- Current challenges in translational pain research
- (2012) Jianren Mao TRENDS IN PHARMACOLOGICAL SCIENCES
- NaV1.7 accumulates and co-localizes with phosphorylated ERK1/2 within transected axons in early experimental neuromas
- (2011) Anna-Karin Persson et al. EXPERIMENTAL NEUROLOGY
- ERK1/2 Mitogen-Activated Protein Kinase Phosphorylates Sodium Channel Nav1.7 and Alters Its Gating Properties
- (2010) S. Stamboulian et al. JOURNAL OF NEUROSCIENCE
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
- (2010) Robert H. Dworkin et al. MAYO CLINIC PROCEEDINGS
- Fyn is involved in angiotensin II type 2 receptor-induced neurite outgrowth, but not in p42/p44mapk in NG108-15 cells
- (2010) M.-O. Guimond et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Overcoming obstacles to developing new analgesics
- (2010) Clifford J Woolf NATURE MEDICINE
- The evidence for pharmacological treatment of neuropathic pain
- (2010) Nanna Brix Finnerup et al. PAIN
- Intraneuronal angiotensinergic system in rat and human dorsal root ganglia
- (2010) Jaspal Patil et al. REGULATORY PEPTIDES
- Cellular and Molecular Mechanisms of Pain
- (2009) Allan I. Basbaum et al. CELL
- Ectopic discharge in Aβ afferents as a source of neuropathic pain
- (2009) Marshall Devor EXPERIMENTAL BRAIN RESEARCH
- Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas
- (2008) Joel A. Black et al. ANNALS OF NEUROLOGY
- Estrogen Elicits Dorsal Root Ganglion Axon Sprouting via a Renin-Angiotensin System
- (2008) Anuradha Chakrabarty et al. ENDOCRINOLOGY
- Phosphorylation of Sodium Channel Nav1.8 by p38 Mitogen-Activated Protein Kinase Increases Current Density in Dorsal Root Ganglion Neurons
- (2008) A. Hudmon et al. JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More